东京热福利视频导航|日韩无码不卡一区|成人高清手机在线|在厨房乱子伦对白一区二区|中文字幕网址导航|国产原创在线亚洲黄色大片高清无码|深爱激情五月丁香亚洲综合社区|成人在线手机视频|浮力影院成人A片|日韩限制电影在线观看

Nanomedicine
  • 數(shù)據(jù)庫(kù)收錄SCIE
  • 創(chuàng)刊年份2006年
  • 年發(fā)文量140
  • H-index93

Nanomedicine

期刊中文名:納米醫(yī)學(xué)ISSN:1743-5889E-ISSN:1748-6963

該雜志國(guó)際簡(jiǎn)稱:NANOMEDICINE-UK,是由出版商Future Medicine Ltd.出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以BIOTECHNOLOGY & APPLIED MICROBIOLOGY研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。

基本信息:
期刊簡(jiǎn)稱:NANOMEDICINE-UK
是否OA:未開放
是否預(yù)警:
Gold OA文章占比:8.87%
出版信息:
出版地區(qū):ENGLAND
出版周期:Monthly
出版語(yǔ)言:English
出版商:Future Medicine Ltd.
評(píng)價(jià)信息:
中科院分區(qū):4區(qū)
JCR分區(qū):Q1
影響因子:4.7
CiteScore:8.1
雜志介紹 中科院JCR分區(qū) JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Nanomedicine雜志介紹

《Nanomedicine》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊,中文名稱納米醫(yī)學(xué),本刊主要出版、報(bào)道醫(yī)學(xué)-BIOTECHNOLOGY & APPLIED MICROBIOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為4.7,最新CiteScore 指數(shù)為8.1。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有:

  • Smart nanostructures for targeted oxygen-producing photodynamic therapy of skin photoaging and potential mechanism

    Author: Wang, Yun; Lu, Zhaopeng; Huang, Yuqi; Jia, Wenyu; Wang, Wandong; Zhang, Xin; Chen, Cheng; Li, Yizhi; Yang, Chunsheng; Jiang, Guan

  • Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells

    Author: Wang, Siying; Han, Feng; Xie, Lanlan; Liu, Yanjie; Yang, Qilei; Zhao, Dongmei; Zhao, Xiuhua

  • Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles

    Author: Bai, Yu-Ting; Zhang, Xue-Qiong; Chen, Xiao-Jie; Zhou, Gang

  • Nanoparticle vaccine based on the envelope protein domain III of Japanese encephalitis virus elicits robust protective immune responses in mice

    Author: Yao, Manman; Ren, Xujiao; Yin, Mengge; Chen, Huanchun; Li, Xiangmin; Qian, Ping

英文介紹

Nanomedicine雜志英文介紹

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.

As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.

Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.

The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.

中科院SCI分區(qū)

Nanomedicine雜志中科院分區(qū)信息

2023年12月升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 4區(qū)
小類:

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程與應(yīng)用微生物 3區(qū)

NANOSCIENCE & NANOTECHNOLOGY
納米科技 4區(qū)

2022年12月升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程與應(yīng)用微生物 3區(qū)

NANOSCIENCE & NANOTECHNOLOGY
納米科技 3區(qū)

2021年12月舊的升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程與應(yīng)用微生物 3區(qū)

NANOSCIENCE & NANOTECHNOLOGY
納米科技 3區(qū)

2021年12月基礎(chǔ)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 2區(qū)
小類:

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程與應(yīng)用微生物 2區(qū)

NANOSCIENCE & NANOTECHNOLOGY
納米科技 3區(qū)

2021年12月升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程與應(yīng)用微生物 3區(qū)

NANOSCIENCE & NANOTECHNOLOGY
納米科技 3區(qū)

2020年12月舊的升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程與應(yīng)用微生物 3區(qū)

NANOSCIENCE & NANOTECHNOLOGY
納米科技 3區(qū)

中科院SCI分區(qū):是中國(guó)科學(xué)院文獻(xiàn)情報(bào)中心科學(xué)計(jì)量中心的科學(xué)研究成果。期刊分區(qū)表自2004年開始發(fā)布,延續(xù)至今;2019年推出升級(jí)版,實(shí)現(xiàn)基礎(chǔ)版、升級(jí)版并存過(guò)渡,2022年只發(fā)布升級(jí)版,期刊分區(qū)表數(shù)據(jù)每年底發(fā)布。 中科院分區(qū)為4個(gè)區(qū)。中科院分區(qū)采用刊物前3年影響因子平均值進(jìn)行分區(qū),即前5%為該類1區(qū),6%~20%為2區(qū)、21%~50%為3區(qū),其余的為4區(qū)。1區(qū)和2區(qū)雜志很少,雜志質(zhì)量相對(duì)也高,基本都是本領(lǐng)域的頂級(jí)期刊。

JCR分區(qū)(2023-2024年最新版)

Nanomedicine雜志 JCR分區(qū)信息

按JIF指標(biāo)學(xué)科分區(qū)
學(xué)科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY
收錄子集:SCIE
分區(qū):Q1
排名:29 / 174
百分位:

83.6%

學(xué)科:NANOSCIENCE & NANOTECHNOLOGY
收錄子集:SCIE
分區(qū):Q2
排名:55 / 140
百分位:

61.1%

按JCI指標(biāo)學(xué)科分區(qū)
學(xué)科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY
收錄子集:SCIE
分區(qū):Q2
排名:82 / 174
百分位:

53.16%

學(xué)科:NANOSCIENCE & NANOTECHNOLOGY
收錄子集:SCIE
分區(qū):Q2
排名:64 / 140
百分位:

54.64%

JCR分區(qū):JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。

CiteScore 評(píng)價(jià)數(shù)據(jù)(2024年最新版)

Nanomedicine雜志CiteScore 評(píng)價(jià)數(shù)據(jù)

  • CiteScore 值:8.1
  • SJR:0.67
  • SNIP:0.562
學(xué)科類別 分區(qū) 排名 百分位
大類:Social Sciences 小類:Development Q1 26 / 306

91%

大類:Social Sciences 小類:Medicine (miscellaneous) Q1 51 / 398

87%

大類:Social Sciences 小類:General Materials Science Q1 99 / 463

78%

大類:Social Sciences 小類:Biomedical Engineering Q1 66 / 303

78%

大類:Social Sciences 小類:Bioengineering Q2 44 / 162

73%

歷年影響因子和期刊自引率

投稿經(jīng)驗(yàn)

Nanomedicine雜志投稿經(jīng)驗(yàn)

該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在BIOTECHNOLOGY & APPLIED MICROBIOLOGY綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過(guò)審時(shí)間都較長(zhǎng),投稿過(guò)審時(shí)間平均 約6.0個(gè)月 ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢客服。

免責(zé)聲明

若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商:FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB。